Our findings extend previous studies which proposed that a combination of either KLK3 with PSMA or KLK3 with KLK2 might most precisely identify PC metastases and predict biochemical recurrence [15, 28]. This evidence concerns the gene FOLH1 and pachyonychia congenita.